Researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in ‘primary’ immune cells — those drawn directly from patients. The new method, described in the Nov. 15 issue of Cell, provides researchers with a powerful tool that will guide their decision-making when determining how best to engineer immune cells to fight cancer and a host of other diseases.